The Seattle Hub for Synthetic Biology is receiving a $10 million grant to support the training of new scientists and the ...

What if China decided to sever American access to the drug ingredients your sick kid depends on? But America’s losing ...

Synthetic biology holds much promise for the life sciences sector as it continues to look for new ways of treating disease and accelerating drug development, says Debiopharm's Tanja Dowe.

Colossal CEO Ben Lamm reaffirmed that the company has no plans to create a real-life Jurassic Park — and said that humanity ...

The rapid diversification of synthetic biology tools holds promise in making some classically hard-to-solve environmental problems tractable. Here we review longstanding problems in the Earth and ...

Washington Research Foundation (WRF) has pledged $10 million over five years in support of a new program led by UW Medicine's Brotman Baty Institute (BBI) and the Allen Institute. The program, ...

Colossal Biosciences co-founder and CEO Ben Lamm is in Austin for South by Southwest 2025 to discuss how the company is ...

Researchers at Yale have achieved a major breakthrough in synthetic biology. They have rewritten the genetic code of an ...

A synthetic microbiome therapy, tested in mice, protects against severe symptoms of a gut infection that is notoriously ...